Search results for "Allele specific"

showing 2 items of 2 documents

Evaluating the effect of spastin splice mutations by quantitative allele-specific expression assay

2010

Background:  Mutations in the SPG4/SPAST gene are the most common cause for hereditary spastic paraplegia (HSP). The splice-site mutations make a significant contribution to HSP and account for 17.4% of all types of mutations and 30.8% of point mutations in the SPAST gene. However, only few studies with limited molecular approach were conducted to investigate and decipher the role of SPAST splice-site mutations in HSP. Methods:  A reverse transcriptase-polymerase chain reaction (RT-PCR) analysis and quantitative allele-specific expression assay were performed. Results:  We have characterized the consequence of two novel splice-site mutations (c.1493 + 1G>A and c.1414−1G>A) in the SPAST gene…

Genetics0303 health sciencesbusiness.industryHereditary spastic paraplegiaPoint mutationSpastinmedicine.disease03 medical and health sciencesExon0302 clinical medicineNeurologyRNA splicingMedicinespliceNeurology (clinical)businessSPAST gene030217 neurology & neurosurgeryAllele specific030304 developmental biologyEuropean Journal of Neurology
researchProduct

Allele-specific silencing as therapy for familial amyotrophic lateral sclerosis caused by the p.G376D TARDBP mutation

2022

Abstract Amyotrophic lateral sclerosis is a neurodegenerative disease characterized by the degeneration of motor neurons. There is no treatment for this disease that affects the ability to move, eat, speak and finally breathe, causing death. In an Italian family, a heterozygous pathogenic missense variant has been previously discovered in Exon 6 of the gene TARDBP encoding the TAR DNA-binding protein 43 protein. Here, we developed a potential therapeutic tool based on allele-specific small interfering RNAs for familial amyotrophic lateral sclerosis with the heterozygous missense mutation c.1127G>A. We designed a small interfering RNA that was able to diminish specifically the express…

antisense oligonucleotideCellular and Molecular NeurosciencePsychiatry and Mental healthsiRNA therapyNeurologyallele-specific silencingTDP-43ALS TDP43 siRNA therapy antisense oligonucleotides allele specific silencingSettore MED/26 - NeurologiaALSantisense oligonucleotidesSettore MED/03 - GENETICA MEDICABiological Psychiatry
researchProduct